Longitudinal Safety Outcomes of Anti-tumor Necrosis Factor Alpha Therapy in the Treatment of Inflammatory Bowel Disease
Related Posts
Elliott J, Webb NE, Ruiz P, Cho GD, Ali A, Anton PA, Yang OO, Fulcher JA. An ex vivo gut mucosal explant assay to compare[...]
LIFT-HCC Investigators; Rezaee-Zavareh MS, Wang T, Tabrizian P, Yeo YH, Ji F, Adetyan H, Luu M, Zhong S, Marino R, Ward SC, Abdelrahim M, Esmail[...]
Wigston L, Ahmed M, Abebe Z, Pandol SJ, Melaku YA, Barreto SG. Risk Factor Profiles May Differ Between Younger-Onset and Late-Onset Colorectal Cancer: An Exploratory[...]